SciELO - Scientific Electronic Library Online

 
vol.110 issue2A question about dyspeptic patients analyzed using psychometric scoresPost-transplant lymphoproliferative disease after liver transplantation author indexsubject indexarticles search
Home Pagealphabetic serial listing  

My SciELO

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Española de Enfermedades Digestivas

Print version ISSN 1130-0108

Rev. esp. enferm. dig. vol.110 n.2 Madrid Feb. 2018

https://dx.doi.org/10.17235/reed.2017.5390/2017 

LETTERS TO THE EDITOR

Cystic pancreatic neuroendocrine tumors

Modesto-J. Varas1  , Carme Loras1  , Agustí Balboa1 

1Unidad de Ecoendoscopia Digestiva y Servicio de Anatomía Patológica. Centro Médico Teknon Quirón Salud. Barcelona. España

Key words: Cystic pancreatic neuroendocrine tumor; Pancreatic endocrine or neuroendocrine tumor; Endoscopic ultrasonography

Dear Editor,

Cystic pancreatic neuroendocrine tumors (cPNETs) represent less than 8% of all pancreatic cysts and approximately 13% 1 of pancreatic endocrine tumors (PNETs).

According to a recent review 1, the percentage of non-functional (NF) PNETs is 85% and 44.6% are incidentalomas. In our series of 75 PNET cases, ten cPNET cases (13%) were identified which are discussed and summarized below (Table 1).

Table 1 Characteristics of ten cases 

Case report

A 41-year-old asymptomatic male underwent a routine checkup via ultrasonography (US) and computed tomography (CT) and a 20 mm cyst was identified in the pancreatic tail (incidentaloma). Subsequently, a unilocular cystic lesion of 17 x 25 mm in size was identified in the pancreatic tail via 5 and 7.5 MHz EUS. Transgastric fine needle aspiration (FNA) (one pass) was performed with a 22G needle. Cytological analysis identified a chromogranin, synaptophysin-positive cystic pancreatic neuroendocrine tumor. The patient subsequently underwent surgery.

Discussion

According to the literature, cPNETs are usually non-functional, asymptomatic growths but may also be associated with multiple endocrine neoplasia (MEN). Occasionally, they are functional lesions (gastrinoma, etc.) and most of them are benign with a good prognosis, as in this case.

cPNETs may be incidental findings during imaging studies (US, contrast enhanced ultrasound [CEUS], CT and magnetic resonance imaging [MRI]) or endoscopic procedures, as occurred with most of our patients.

In a series of 19 cPNETs collected over 12 years, two patients had MEN (10.5%) and two had metastatic disease (10.5%). FNA-EUS effectiveness was 63% and low CEA levels were found in the cystic fluid 2.

In the most recent reported series with cohorts of more than 50 cases 3) (4) (5, most lesions were NF PNETs and incidentalomas, which is consistent with our series. We believe the percentage of incidentalomas and NF cPNETs is higher than 80%, with numbers reaching 95% in the most extensive series thus far reported (5). In the review by Hurtado-Pardo et al. (1), NF PNET were estimated to account for 85% of cases, whereas incidentalomas represent 44.6% of cases. We feel that this is lower than the actual rate.

Bibliografía

1. Hurtado-Pardo L, Cienfuegos JA, Ruiz-Canela M, et al. Cystic pancreatic neuroendocrine tumors (cPNETs): A systematic review and meta-analysis of case series. Rev Esp Enferm Dig 2017;109:778-87. DOI: 10.17235/reed.2017.5044/2017 [ Links ]

2. Yoon WJ, Daglilar ES, Pitman MB, et al. Cystic pancreatic neuroendocrine tumors: Endoscopic ultrasound and fine-needle aspiration characteristics. Endoscopy 2013;45:189-94. DOI: 10.1055/s-0032-1325990 [ Links ]

3. Ridtitid W, Halawi H, De Witt JH, et al. Cystic PNETs: Outcomes of preoperative endosonography-guided fine needle aspiration; and recurrence during long-term follow-up. Endoscopy 2015;47:617-25. DOI: 10.1055/s-0034-1391712 [ Links ]

4. Paiella S, Marchegiani G, Miotto M, et al. Are cystic pancreatic neuroendocrine tumors an indolent entity results from a single-center surgical series. Neuroendocrinology 2017. DOI: 10.1159/000477849 [ Links ]

5. Bletsis P, Carr R, Roch W. Cystic pancreatic neuroendocrine tumors: A more favoralable lesion? HPB 2017;19(Suppl 1):S41-2. DOI: 10.1016/j.hpb.2017.02.022 [ Links ]